Giovanni Battista Levi Sandri1, Gabriele Spoletini2, Giovanni Vennarecci3, Elisa Francone2, Mohammed Abu Hilal4, Giuseppe Maria Ettorre3. 1. Division of General Surgery and Liver Transplantation, San Camillo Hospital, Rome, Lazio, Italy. gblevisandri@gmail.com. 2. University Hospital Southampton NHS Foundation Trust, Southampton, UK. 3. Division of General Surgery and Liver Transplantation, San Camillo Hospital, Rome, Lazio, Italy. 4. University Hospital Southampton NHS Foundation Trust, Southampton, UK. Abuhilal9@gmail.com.
Abstract
OBJECTIVE: In this study, we aim to assess the impact of tumor size on clinical and oncological outcomes in patients undergoing laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC). BACKGROUND: LLR has been shown to be feasible, safe, and oncologically efficient. However, it has been slow to develop in patients with HCC who often suffer from chronic liver disease which represents an additional challenge for the surgeon. The experience with large HCCs is even more limited. METHODS: Between 2003 and 2016, 172 patients from two high-volume liver surgery centers underwent LLR for HCC. Prospectively collected data were analyzed after stratification in 3 groups according to tumor major diameter (group 1: < 3 cm; group 2: between 3 and 5 cm; group 3: ≥ 5 cm). Perioperative and long-term outcomes were compared between the three groups and sub-analyses were carried out on the extent and location of the resections. RESULTS: Groups 1, 2, and 3 consisted of 82, 52, and 38 patients, respectively. Minor and major resections were performed in 98.8% and 1.2% in group 1, in 90.4% and 9.6% in group 2, and in 68.4% and 31.6% in group 3, respectively. Postero-superior "technically major" resections were performed in 15.8% patients in group 1, in 19.2% in group 2, and in 15.8% in group 3, respectively. Group 3 had higher conversion rates (p < 0.001), more frequent (p = 0.056) and more prolonged (p = 0,075) pedicle clamping and longer operative time (p < 0.001), higher blood losses (p = 0.025), and longer total hospital and intensive care unit stays. These differences ceased after removing the major resections from the study population, except for the postoperative length of stay. There were no differences in morbidity, mortality, completeness of resection rates, and long-term outcomes between the three groups. CONCLUSION: LLR for HCC appears to be safe and oncologically efficient when performed in high-volume HPB and laparoscopic centers. Tumor size does not appear to impact negatively on the outcomes except for postoperative hospital stay.
OBJECTIVE: In this study, we aim to assess the impact of tumor size on clinical and oncological outcomes in patients undergoing laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC). BACKGROUND: LLR has been shown to be feasible, safe, and oncologically efficient. However, it has been slow to develop in patients with HCC who often suffer from chronic liver disease which represents an additional challenge for the surgeon. The experience with large HCCs is even more limited. METHODS: Between 2003 and 2016, 172 patients from two high-volume liver surgery centers underwent LLR for HCC. Prospectively collected data were analyzed after stratification in 3 groups according to tumor major diameter (group 1: < 3 cm; group 2: between 3 and 5 cm; group 3: ≥ 5 cm). Perioperative and long-term outcomes were compared between the three groups and sub-analyses were carried out on the extent and location of the resections. RESULTS: Groups 1, 2, and 3 consisted of 82, 52, and 38 patients, respectively. Minor and major resections were performed in 98.8% and 1.2% in group 1, in 90.4% and 9.6% in group 2, and in 68.4% and 31.6% in group 3, respectively. Postero-superior "technically major" resections were performed in 15.8% patients in group 1, in 19.2% in group 2, and in 15.8% in group 3, respectively. Group 3 had higher conversion rates (p < 0.001), more frequent (p = 0.056) and more prolonged (p = 0,075) pedicle clamping and longer operative time (p < 0.001), higher blood losses (p = 0.025), and longer total hospital and intensive care unit stays. These differences ceased after removing the major resections from the study population, except for the postoperative length of stay. There were no differences in morbidity, mortality, completeness of resection rates, and long-term outcomes between the three groups. CONCLUSION: LLR for HCC appears to be safe and oncologically efficient when performed in high-volume HPB and laparoscopic centers. Tumor size does not appear to impact negatively on the outcomes except for postoperative hospital stay.
Authors: Mark J W McPhail; Tina Scibelli; Mahmoud Abdelaziz; Amin Titi; Neil W Pearce; Mohammed Abu Hilal Journal: Expert Rev Gastroenterol Hepatol Date: 2009-08 Impact factor: 3.869
Authors: Vishal G Shelat; Federica Cipriani; Tiago Basseres; Thomas H Armstrong; Arjun S Takhar; Neil W Pearce; Mohammad AbuHilal Journal: Ann Surg Oncol Date: 2014-09-26 Impact factor: 5.344
Authors: F Cipriani; M Rawashdeh; L Stanton; T Armstrong; A Takhar; N W Pearce; J Primrose; M Abu Hilal Journal: Br J Surg Date: 2016-08-03 Impact factor: 6.939
Authors: Mohammad Abu Hilal; Luca Aldrighetti; Ibrahim Dagher; Bjorn Edwin; Roberto Ivan Troisi; Ruslan Alikhanov; Somaiah Aroori; Giulio Belli; Marc Besselink; Javier Briceno; Brice Gayet; Mathieu D'Hondt; Mickael Lesurtel; Krishna Menon; Peter Lodge; Fernando Rotellar; Julio Santoyo; Olivier Scatton; Olivier Soubrane; Robert Sutcliffe; Ronald Van Dam; Steve White; Mark Christopher Halls; Federica Cipriani; Marcel Van der Poel; Ruben Ciria; Leonid Barkhatov; Yrene Gomez-Luque; Sira Ocana-Garcia; Andrew Cook; Joseph Buell; Pierre-Alain Clavien; Christos Dervenis; Giuseppe Fusai; David Geller; Hauke Lang; John Primrose; Mark Taylor; Thomas Van Gulik; Go Wakabayashi; Horacio Asbun; Daniel Cherqui Journal: Ann Surg Date: 2018-07 Impact factor: 12.969
Authors: Federica Cipriani; Vishal G Shelat; Majd Rawashdeh; Elisa Francone; Luca Aldrighetti; Arjun Takhar; Thomas Armstrong; Neil W Pearce; Mohammad Abu Hilal Journal: J Am Coll Surg Date: 2015-03-27 Impact factor: 6.113
Authors: Neil William Pearce; Francesco Di Fabio; Mabel Joey Teng; Shareef Syed; John Neil Primrose; Mohammed Abu Hilal Journal: Am J Surg Date: 2011-08-20 Impact factor: 2.565
Authors: Marcel J van der Poel; Marc G Besselink; Federica Cipriani; Thomas Armstrong; Arjun S Takhar; Susan van Dieren; John N Primrose; Neil W Pearce; Mohammed Abu Hilal Journal: JAMA Surg Date: 2016-10-01 Impact factor: 14.766
Authors: Graziano Ceccarelli; Aldo Rocca; Michele De Rosa; Andrea Fontani; Fabio Ermili; Enrico Andolfi; Walter Bugiantella; Giovanni Battista Levi Sandri Journal: Updates Surg Date: 2021-04-08
Authors: Giovanni Battista Levi Sandri; Giuseppe Maria Ettorre; Luca Aldrighetti; Umberto Cillo; Raffaele Dalla Valle; Alfredo Guglielmi; Vincenzo Mazzaferro; Alessandro Ferrero; Fabrizio Di Benedetto; Salvatore Gruttadauria; Luciano De Carlis; Giovanni Vennarecci Journal: Surg Endosc Date: 2018-09-10 Impact factor: 4.584